• Explore /
  • Poster
  • / A phase I, randomized, controlled, multicentre trial of isolated hepatic perfusion in combination with ipilimumab and nivolumab in patients with uveal melanoma metastases (the SCANDIUM 2 trial).

A phase I, randomized, controlled, multicentre trial of isolated hepatic perfusion in combination with ipilimumab and nivolumab in patients with uveal melanoma metastases (the SCANDIUM 2 trial).

Abstract Poster

Authors

Roger Olofsson Bagge

Roger Olofsson Bagge

Department of Surgery, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden

Roger Olofsson Bagge , Axel Nelson , Amir Shafazand , Christian Cahlin , Ana Carneiro , Hildur Helgadottir , Max Levin , Magnus Rizell , Gustav J. Ullenhag , Sara Wirén , Per Lindner , Jonas A Nilsson , Lars Ny

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Melanoma/Skin Cancers

Track

Melanoma/Skin Cancers

Sub Track

Advanced/Metastatic Disease

Clinical Trial Registration Number

NCT04463368

Citation

J Clin Oncol 41, 2023 (suppl 16; abstr 9533)

DOI

10.1200/JCO.2023.41.16_suppl.9533

Abstract #

9533

Poster Bd #

296

Abstract Disclosures

Similar Posters

First Author: Thaïs M.L. Tong

First Author: Thaïs M.L. Tong

First Author: Roger Olofsson Bagge

First Author: Kamaneh Montazeri